Skip to content
The Kids Research Institute Australia logo

Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared

Citation:
Martinon-Torres F, Wysocki J, Szenborn L, …….. Richmond P, Gilbert C, … et al. Corrigendum to “A Phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of V114 compared with PCV13 in healthy infants (PNEU-PED-EU-1)”. Vaccine. 2025;48.